Notal Vision Launches First U.S. Home OCT Longitudinal Study with Patient Self-operated Device

...er of the Roche Group. “The start of the first US study marks a key milestone for our Home OCT program,” said Kester Nahen, PhD, CEO of Notal Vision, Inc. “We are excited about support from Genentech given its storied hi...
Read Full Article